ARCHIVES

Six Institutions Get Awards For LAK-IL-2 Trials

This article is from The Cancer Letter archive.

Vol. 12 No. 06 | February 7, 1986

Download PDF Visit The Full Archive

Related Articles

Scientists Defend NCI, Criticize Post Series As Inaccurate

November 20, 1981

FDA Advisors Unanimously Turn Down GPC Biotech’s Orplatna for Prostate Cancer.

July 27, 2007

FDA, NCI Near Agreement On Handling INDs

January 28, 1977

In Brief: NCAB To Protest Tobacco Ads In ‘Family Circle’; ACS Petitions For Taxol Source Designation

October 19, 1990

Grants Funding: FY(& Year-End Report By NCI On Paylines

October 10, 1997

Community Clinical Oncology Program Renewed, NCI Hopes To Restore Cuts In ’08.

March 30, 2007